Overexpression of key KP enzymes, including IDO and tryptophan 2,3-dioxygenase (TDO), is frequently observed in CNS tumor cells, such as gliomas, leading to significantly elevated levels of kynurenine [14,173]. This evidence concerns the gene IDO1 and glioma.